Field Guide · Deconstructed
If you go looking for a mold/CIRS protocol, two names come up over and over: Ritchie Shoemaker and Neil Nathan. Parents often think they have to pick a side. You don’t. Shoemaker is the original — the systematized, lab-driven, biomarker-anchored protocol that mapped the whole illness. Nathan is the gentler, individualized approach built for the sensitive patient — the kid who flares on the standard protocol and can’t tolerate the deep end. This entry lays them side by side, tells you honestly where each is strong and where each is debated, and shows you the Plan B synthesis: they’re complementary, not opposed. Pair this with the full mold treatment sequence.
I walked this part of the labyrinth myself — knocked on the doors, read the research, and came back with the map. You don’t have to find the way out alone.
Both protocols treat mold biotoxin illness (CIRS) — the chronic inflammatory state that drives brain fog, anxiety, dysregulation, and the inability to tolerate other treatments. The difference isn’t what they target; it’s how they get there: Shoemaker by a defined biomarker-and-sequence protocol, Nathan by a slow, nervous-system-first approach for the very sensitive. The honest caveat, same as always: only testing — the home plus the child’s mycotoxin/CIRS picture — tells you whether mold is actually your child’s driver in the first place.
Dr. Ritchie Shoemaker is the physician who first defined and systematized chronic inflammatory response syndrome (CIRS). He built the model: the HLA-DR genetics, the inflammatory biomarker panel, the VCS screen, and the famous step-by-step treatment protocol that follows a fixed order. It is rigorous, lab-anchored, and reproducible — the closest thing the field has to a standardized map.
Dr. Neil Nathan — author of Toxic and a clinician known for the hardest, most reactive cases — came at the same illness from the other end. His central observation: a meaningful subset of patients (and very often kids) are so sensitive that the standard protocol makes them worse. They flare on the first binder, herx relentlessly, and react to almost everything. For them, Nathan reorders the front end: calm the nervous system, open drainage, and go low-and-slow before you ask the body to mobilize anything.
The short version: Shoemaker gives you the map and the sequence. Nathan gives you the pacing for a child who can’t run that sequence at full speed. Neither cancels the other.
Here is where the two approaches actually differ — row by row. Read it as two valid styles for the same illness, not a winner-take-all.
| Shoemaker | Nathan | |
|---|---|---|
| Core philosophy | Protocolized & biomarker-driven. A defined illness with a defined sequence; measure, treat the step, re-measure. | Individualized & nervous-system-first. Meet the patient where their reactivity is; calm the system before mobilizing. |
| Diagnosis & labs | The VCS screen plus the full biomarker panel — C4a, TGF-β1, MMP-9, MSH, VIP — on top of HLA-DR/DQ genetics. Lab-anchored, reproducible. | Clinical picture first, selective labs second. Uses biomarkers where useful but is less rigid about the full panel; treats the patient in front of him. |
| Starting point | Remove exposure → binders early. Once the environment is handled, the protocol moves to cholestyramine relatively quickly. | Calm the system first. Limbic retraining, vagal tone, and drainage come before binders in the hypersensitive child. |
| Binders | Cholestyramine (CSM) / Welchol are central — the prescription bile-acid sequestrants anchor the 12-step protocol. | Gentle and rotated, often starting much lower — titrate up from minuscule doses as the child tolerates. |
| Pace | A defined sequence with expected timelines; move to the next step when the prior one is met. | Low-and-slow, paced to the patient’s reactivity. A flare means slow down, not push through. |
| MARCoNS / nasal | A defined step — compounded BEG spray after binders have been running, tied to the MSH picture. | Addresses the nose, but cautiously — later, gentler, only once the child is stable enough to handle it. |
| VIP | The protocol’s final step — VIP nasal spray, with hard prerequisites (no exposure, no MARCoNS, normalized VCS). | Used selectively, when indicated, not as a fixed capstone of a sequence. |
| Best fit | A child (or adult) who can tolerate a systematic, lab-anchored baseline — gives you a measurable map and a clear order of operations. | The very sensitive, herx-prone kid who can’t tolerate the standard protocol — flares on everything, needs the system calmed first. |
Sources: Shoemaker / survivingmold.com — the biotoxin pathway & CIRS biomarkers · survivingmold.com — 12-step protocol overview · Neil Nathan MD — Toxic (the sensitive-patient framework) · Nathan — common mistakes / drainage-before-binders
Neither of these is “proven” in the RCT sense for pediatric PANS. Both are clinical frameworks built from practice and case experience, not from randomized controlled trials in children. That’s the truth, and any honest version of this has to lead with it.
Shoemaker’s biomarker model is the more systematized — it gives you objective numbers to track and a reproducible sequence, which is genuinely valuable. But parts of it remain debated in mainstream medicine: some of the specific biomarkers (and how tightly they map to illness) are contested, and the protocol’s rigidity can be too much for a fragile kid.
Nathan’s gentleness is clinically wise for sensitive children — it’s the right instinct for the kid who flares on everything — but it is less protocolized, which means more depends on the individual clinician’s judgment and less on a checklist you can hold them to. Each strength is the other’s weakness. That’s exactly why pairing them works.
Here’s the read that resolves the false choice.
Take Shoemaker’s order of operations, run it at Nathan’s pace. For a herx-prone PANS kid, that’s the whole answer in one sentence. Shoemaker tells you what comes before what — the sequence that, done out of order, makes kids worse. Nathan tells you how slowly to move through it so a sensitive child doesn’t get flattened.
Concretely, for the sensitive child:
That blend — Shoemaker’s map, Nathan’s pacing — is what a good integrative clinician actually does for a fragile kid, even if they’d name only one of the two protocols. The full step-by-step version, with the kid-safe front-loading already built in, lives in the mold treatment protocol entry ›
Which approach (or blend) fits your child? Start at the top. Tap to open.
Not yet → neither protocol applies. Confirm the home + the child’s picture first — see find-mold and the body-side tests in the mold protocol. Yes, mold is on the table → continue ↓
Very sensitive / herx-prone / reacts to most things → lead with Nathan’s pacing — calm the system, micro-dose, go low-and-slow. Relatively robust, can tolerate a defined sequence → a Shoemaker-style lab-anchored baseline gives you measurable footing.
That’s the blend — and it’s the usual right answer for a PANS kid. Use Shoemaker’s order of operations (remove → drainage → binders → nasal once you know MSH) at Nathan’s pace (system first, micro-dose, watch). The combined sequence is laid out in the mold protocol.
You’re mobilizing faster than you’re draining — this is exactly the failure mode Nathan’s pacing exists to prevent. Back off the binder, open drainage harder, slow down, then resume lower. The full antidote is in the mold protocol.
You don’t have to referee these two protocols alone. Minta reads your child’s CIRS labs, HLA, mycotoxin panel, and — just as important — how reactive they actually are, and tells you which approach (or which blend) fits: Shoemaker’s map, Nathan’s pace, or both. Then she walks the sequence with you, step by step. Let Minta sort this with you →
Credentials, polish, and how conventional an approach sounds tell you little about whether a practitioner will help your child — or harm them. What does: their behavior and their incentives. Watch those.
A good mold clinician isn’t loyal to one protocol — they’re loyal to your child. The ones worth trusting borrow the map from Shoemaker and the pacing from Nathan, and adjust to the kid in front of them. Be wary of anyone who runs a single rigid protocol no matter how the child responds — or, on the other end, anyone so “individualized” that there’s no measurable order of operations at all.
Shoemaker and Nathan aren’t rival teams — they’re two halves of the same answer. Shoemaker is the original, systematized, lab-driven CIRS protocol: he built the biomarker map (VCS, C4a, TGF-β1, MMP-9, MSH, VIP, HLA-DR) and the fixed sequence. Nathan is the sensitive-patient approach: nervous-system-first, gentle binders, low-and-slow, for the kid who can’t tolerate the standard protocol. Each one’s strength is the other’s gap. For a herx-prone PANS kid, the Plan B read is simple: follow Shoemaker’s order of operations at Nathan’s pace — calm the system first, micro-dose, watch, and never push through a flare. The full combined sequence lives in the mold treatment protocol. The evidence here is clinical and framework-driven, not RCT-clean — bring it to your team as questions, not instructions. This is parent education, not medical advice.
Plan B does not partner with drug companies or doctors, and we never endorse anyone whose healing isn’t verified by families. We show you the options and how to vet them yourself — and we’re building parent verification: look up a practitioner and see real family reviews before you trust them. Universal bad reviews? Skip.